Tissue Engineering Market

Tissue Engineering Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Graft (Allografts, Autografts and Xenografts), Area of Application (Bone Healing, Burn Healing, Surgical Healing, Wound Healing, and Others), Type of Material of Scaffold (Bone Tissue, Collagen-based Tissue, Human Placental Tissue, Other Animal Based Tissue, Other Human Tissue, Stem Cell and Others Tissues), Type of End User (Ambulatory Surgical Centers / Hospitals / Specialty Clinics) And Key Geographies (North America, Europe, Asia, Latin America, Middle East and North Africa and Rest of the World)

  • Lowest Price Guaranteed From USD 4,799

  • Companies Covered
    129

  • Pages
    278

  • View Count
    12993

From commercial point of view, allograft is the most reasonable option as, from safety point of view, the accommodation of the autologous cells in tissue engineering is a challenging process

-- Head, Cell and Tissue Culture Laboratory, a large-sized organization

Tissue Engineering Market Size & Analysis

The global tissue engineering market size is projected to grow from USD 4.3 billion in 2024 to USD 12.7 billion by 2035, exhibiting a CAGR of 10.27% during the forecast period.

The growth in the market size over the next decade is likely to be the result of the anticipated surge in the demand for regenerative therapeutics to treat chronic wounds and damaged organs.

Over the years, there has been an increase in accidental injuries and diseases that result in tissue or organ damage. According to a research report, nearly 6% of individuals are projected to be affected by chronics wounds across the globe. In the United States, 6.5 million individuals are projected to be affected with chronic wounds. Conventional approaches to treat chronic wounds put a financial burden of over USD 25 billion annually on the United States Healthcare system. Further, the traditional wound treatment process involves the transplantation of damaged tissues, organs, and parts of the body. Traditional transplantation treatment is expensive and is believed to account for over 5% of the NHS (National Healthcare Services) expenditure in the health system. However, with the rising incidence of accidental injuries, congenital abnormalities, and diseases that result in the loss of tissues in humans, there has been a surge in the requirement for advanced treatment modalities. To address the concern, regenerative medicine and tissue engineering emerge as potential solutions to treat chronic wounds. Tissue engineering refers to the techniques used to generate tissues to replace or repair damaged tissues and restore body function.

Currently, over 160 tissue engineering products and regenerative therapeutic products have been / are being developed by various tissue engineering companies established globally. The average cost associated with tissue engineering treatment is estimated to be between USD 1,800 to USD 3,000, making it a viable option for the treatment of chronic wound care. Furthermore, tissue engineering products have shown significant potential to regenerate damaged tissues of bones and skin and also cure congenital abnormalities. Driven by the significance offered by tissue engineering products, such as faster regeneration, improved biocompatibility, affordability, and easy availability, the tissue engineering market is gaining the enormous attention of various players and strategic investors. It is worth highlighting here that several industrial stakeholders have raised around USD 2 billion in the past few years, aiming to elaborate research to explore a wide range of tissue engineering products. The research primarily focused on wound healing, bone healing, and burn healing.

Moreover, more than 800 grants have been awarded by various academic and government organizations active in the tissue engineering industry. Owing to the increasing efforts of industrial players and researchers, there has been significant growth in the number of patients filed / granted in this field. Additionally, with the advances in novel technologies, various complexities associated with tissue reconstruction have been eradicated, predicting the development of advanced tissue engineering procedures to treat wounds. Driven by the ongoing innovation in this industry and the growing shift towards tissue engineering from conventional transplantation, we believe that the tissue engineering market size will grow substantially over the forecast period.

Tissue Engineering Market Segmentation Insights

The market research report presents an in-depth analysis of various companies that are involved in the global tissue engineering industry across different segments, as defined in the table below:

Key Report Attributes

Details

Historical Trend

2019-2023

Base Year

2023

Forecast Period

2024-2035

Market Size 2024

USD 4.3 Billion

Market Size 2035

USD 12.7 Billion

Type of Graft

  • Allografts
  • Autografts 
  • Xenografts

Area of Application

  • Bone Healing
  • Burn Healing 
  • Surgical Healing
  • Wound Healing 
  • Others 

Type of Material of Scaffold

  • Bone Tissue
  • Collagen-based Tissue
  • Human Placental Tissue
  • Other Animal Based Tissue
  • Other Human Tissue
  • Stem Cell
  • Others Tissues

Type of End User

  • Ambulatory Surgical Centers
  • Hospitals
  • Specialty Clinics

Key Geographical Regions

  • North America 
  • Europe
  • Asia-Pacific 
  • Latin America
  • Middle East and North Africa 
  • Rest of the World
Key Companies in the Tissue Engineering Market Profiled
  • AlloSource
  • BioTissue
  • Integra LifeSciences
  • MiMedx
  • Organogenesis
  • Smith + Nephew
  • Tissue Regenix
  • VIVEX Biologics
(A full list of key companies captured is available in the report)

PowerPoint Presentation (Complimentary)

Available

Customization Scope

15% Free Customization Option

Excel Data Packs (Complimentary) 

  • Market Landscape-Tissue Engineering Based Skin Regeneration Products 
  • Market Landscape-Tissue Engineering Based Bone Regeneration Products 
  • Companies Competitiveness Analysis
  • Partnerships and Collaborations Analysis 
  • Patent Analysis 
  • Grants Analysis 
  • Funding and Investment Analysis 
  • Market Forecast and Future Opportunity Analysis

 

The key objective of the market report is to provide a detailed tissue engineering market analysis in order to estimate the existing market size, market value, statistics, and future opportunities for the tissue engineering companies during the forecast period. Additionally, it features market size projections, wherein both the current and upcoming opportunity is segmented across [A] type of graft (allografts / autografts / xenografts), [B] area of application (bone healing / burn healing / surgical healing / wound healing / others), [C] type of material of scaffold (bone tissue, collagen-based tissue, human placental tissue, other animal-based tissue, other human tissue, stem cell and others tissues) and [D] key geographies (North America, Europe, Asia, Latin America, Middle East and North Africa and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three tissue engineering market forecast scenarios, namely the conservative, base, and optimistic scenarios, which represent different tracks of the industry's evolution.

Tissue Engineering Market Share Insights

Market Share by Types of Grafts

Based on the type of grafts, the tissue engineering market is segmented into allografts, autografts, and xenografts. Presently, allografts are dominating the market and are poised to capture 45% of overall revenue share by 2035. In the long run, autografts are likely to show substantial growth and are anticipated to grow at a CAGR of 19.12% during the forecast period.

Market Share by Area of Application

Based on the area of application, the tissue engineering market is segmented into bone healing, burn healing, surgical healing, wound healing, and others. According to our projection, wound healing tissue engineering applications are dominating the market and are estimated to capture 59.57% of the overall revenue share by 2035. The growth can be attributed to the increasing demand for tissue engineering and regenerative medicines for treating chronic wounds.

Market Share by Key Geographical Region

This segment highlights the distribution of the tissue engineering market across various geographies, such as North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and the Rest of the World. According to our projections, North America is expected to hold 63.83% of revenue share by 2035. Notably, the Asia-Pacific market is likely to grow at a CAGR of 10.96% from 2024-2035. In recent years, North America has witnessed a significant increase in funding and research activities initiated by the key players in this industry.

Tissue Engineering Market Key Insights

The “Tissue Engineering Market, Distribution by Type of Graft (Allografts, Autografts and Xenografts), Area of Application (Bone Healing, Burn Healing, Surgical Healing, Wound Healing, and Others), Type of Material of Scaffold (Bone Tissue, Collagen-based Tissue, Human Placental Tissue, Other Animal Based Tissue, Other Human Tissue, Stem Cell and Others Tissues), Type of End User (Ambulatory Surgical Centers / Hospitals / Specialty Clinics) And Key Geographies (North America, Europe, Asia, Latin America, Middle East and North Africa and Rest of the World): Industry Trends and Global Forecasts, Till 2035” market report features an extensive study of the current market landscape, market size, market share, market forecast, market outlook and future opportunities for the tissue engineering companies. The market research report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in providing tissue engineering-based regeneration products.

Competitive Landscape of Tissue Engineering Market

Currently, the market landscape features several industrial and non-industrial leaders that have required expertise for the development of tissue engineering products. Overall, the market is well-fragmented and features small, mid-sized, and large companies. It is worth highlighting here that more than 150 products are offered by nearly 60 tissue engineering companies that are currently engaged in the tissue engineering market. North America and Europe emerge as the hub, remarking the presence of the highest numbers of companies in the tissue engineering industry. Moreover, 30% of the players active in the tissue engineering market are mid-sized companies.

Need for Regenerative Medicines or Tissue Engineering

The current chronic wound and bone healing treatment is characterized by a variety of unmet needs, such as rejection of donor tissue, wound infection, and high cost of transplantation. It is worth noting here that 450+ million cases of acute / long-term symptoms of fractures have been noticed globally that result in permanent loss of human body functions. Furthermore, nearly 6% of the global population is anticipated to be affected from chronic wounds across the globe. The growing cases of chronic wounds necessitate tissue engineering for wound and bone healing that is safe, efficient, and effective in healing wounds.

Market Driver: Increasing Demand for Regenerative Medicines

Several factors are propelling the tissue engineering market during the forecast period. One of the significant drivers is a growing requirement for advanced regenerative medicines to treat chronic and degenerative diseases. Further, the high expenses associated with the treatment of degenerative diseases have surged the requirement for innovative and affordable tissue repair procedures. The growing rate of road accidents and degenerative diseases is prompting the requirement for regenerative medicines to regain body function, which is anticipated to drive tissue engineering market growth.

Market Trend Analysis: Technological Advancements to Explore Novel Biomaterials to Support Tissue Growth

At present, researchers are exploring advanced technologies, scaffolds, and biomaterials that can mimic extracellular matrices to support tissue growth. Further, the integration of innovative technologies such as 3D bioprinting technology, organ-on-chip technology, and stem cell therapies with tissue engineering are offering precise control for cell placement and tissue repair. 3D bioprinting enables the development of tissue structures that can be used for drug testing, tissue repair, and organ transplantation. Organ-on-a-chip technology offers a platform and includes a microfluidic system to stimulate the functions of human organs in vitro. This technology allows researchers to conduct studies on tissue responses to therapeutic drugs and diseases. The ongoing technological advancements in the field of tissue engineering and emerging opportunities will drive growth in this industry during the forecast period.

Tissue Engineering Market: Funding and Investment Analysis

Given the growing demand for regenerative medicines and tissue engineering, several industrial stakeholders have foreseen the lucrative growth opportunity in this field and made considerable investments. It is worth noting here that most of the funding by the industrial leaders has been raised via equity, debts, and venture series. In terms of fundraising, debts are one of the popular mechanisms of funding for industrial leaders to increase research on tissue engineering. Furthermore, stakeholders are receiving financial support in the form of grants with the aim of extending research on tissue engineering based on regenerative products. Notably, the number of grants awarded to stakeholders in this domain, specifically in the US, has increased at a CAGR of nearly 160% between 2020-2023. As the research continues for the development of regenerative medicine using tissue engineering, the market will witness a rise in funding activities by industry and non-industry players, which is anticipated to drive the market.

Clinical Trial Analysis: 1300+ Clinical Trials Are Undergoing for Regenerative Medicine

Driven by the increasing demand for regenerative therapies to heal wounds and repair damaged tissues, the market is anticipated to grow at a notable rate during the forecast period. It is interesting to note here that the key players in the tissue engineering market are expanding their research efforts to develop tissue engineering products. Currently, 1300+ clinical trials are undergoing for regenerative medicine and advanced therapy. The primary focus of increasing research and development activities is to determine the applications of tissue engineering beyond skin as well as bone regeneration. Moreover, researchers are also emphasizing on integrating 3D printing technology and harnessing nanotechnology for skin grafting using hydrogels. The ongoing clinical trials and emerging opportunities are driving growth in this field.

Key Players in the Tissue Engineering Market

Examples of key tissue engineering companies engaged in the tissue engineering industry (which have also been profiled in this market report; the complete list of tissue engineering companies is available in the full report) include AlloSource, BioTissue, Integra LifeSciences, MiMedx, Organogenesis, Smith + Nephew, Tissue Regenix and VIVEX Biologics. This market report includes an easily searchable excel database of all the tissue engineering companies worldwide.

Recent Developments in the Tissue Engineering Market

Several recent developments have taken place in the tissue engineering industry. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.

  • In March 2024, Yibing Qyang, Associate Professor of Medicine (Cardiology) and of Pathology at Yale Research, secured a grant worth USD 2 million from NIH. The R01 grant was awarded with the aim of creating an artificial blood vessel by using pluripotent stem cells and tissue engineering. Remarkably, this research intends to establish a foundation for readily available, mechanically active tubes to provide a curative treatment for patients born with single-ventricle congenital heart defects.
  • In January 2024, Researchers at Texas A&M University recently developed 3D-Printed electronic skin (E-skin) using nanoengineered hydrogels that exhibit thermal biosensing and tunable electronic capabilities to sense like human skin.
  • In June 2023, RegenLab entered into a collaboration with Long Island University Brooklyn with the aim of creating an industrial innovation accelerator dedicated to cell therapies and tissue engineering. 
  • In May 2023, AlloSource launched AlloMend® Duo Acellular Dermal Matrix (ADM) to help surgeons repair and reconstruct soft tissue defects for long-term structural support.
  • In January 2023, Zimmer Biomet announced plans to acquire Embody, Inc. US based developer of collagen based implants for soft tissue healing.
List of Tissue Engineering based Regeneration Products Developers from the research report of Roots Analysis This image highlights the geographical distribution of Tissue Engineering based Regeneration Product Developers Viral Vector Manufacturing Market Expert Opinion

Tissue Engineering Market Report Coverage

The market research report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in providing tissue engineering-based regeneration products.

Amongst other elements, the market report features:

  • A detailed review of the current market landscape of tissue engineering products based on several relevant parameters, such as type of graft (allografts / autografts / xenografts), area of application (burn healing / surgical healing / soft tissue skin regeneration / wound healing), type of material of scaffold (collagen-based tissues / human placental tissues / other human tissues / other animal-based tissues / other tissues) and launch year. In addition, the chapter lists the tissue engineering companies providing tissue engineering-based skin regeneration products, along with information on their respective year of establishment, company size (very small / small / mid-sized / large / very large), location of headquarters (North America / Europe / Asia / Rest of the World) and target market (domestic only / both international and domestic).
  • A detailed review of the current market landscape of tissue engineering products based on several relevant parameters, such as type of graft (allografts / xenograft), formulation of product (bone matrix / bone putty / cortical fibers / powder / putty / sheet / sponge block), type of material of scaffold (bone tissue / collagen tissue / others / stem cell) and launch year. In addition, the chapter lists the tissue engineering companies providing tissue engineering-based bone regeneration products, along with information on their respective year of establishment, company size (very small / small / mid-sized / large / very large), location of headquarters (North America / Europe / Asia / Rest of the World) and target market (domestic only / both international and domestic).
  • An in-depth analysis, highlighting the market trends through six different schematic representations, including [A] a world map representation, highlighting the regional distribution of the various tissue engineering products providers, [B] a 4D bubble analysis comparing the key tissue engineering companies engaged in tissue engineering market, based on several relevant parameters (such as year of establishment, company size, number of tissue engineering based-regeneration products offered and region), [C] an insightful spider web representation of tissue engineering based-regeneration products (based on type of graft and area of application), [D] a horizontal stacked bar chart representation presenting the distribution of tissue engineering based-regeneration products providers (based on area of application and material of scaffold), [E] a vertical stacked bar chart representation of tissue engineering-based regeneration products (distribution by product formulation and type of graft) and [F] a vertical stack bar chart representation of tissue engineering based-regeneration products (distribution by region and type of market).

Viral Vector Manufacturing Market Expert Opinion

This image presents the recent initiatives undertaken by players engaged in tissue engineering domain

This image provides information on grants that have been awarded to projects related to Tissue Engineering based Regeneration Products

  • An insightful competitiveness analysis of tissue engineering companies engaged in the development of tissue engineering-based regeneration products, based on several relevant parameters, such as years of experience, portfolio strength (in terms of area of applications, material of scaffold, type of graft, number of products offered), partnerships activity (in terms of number of partnerships, year of partnerships, and type of partnerships), and funding activity (in terms of number of funding instances, amount of funding, year of funding, type of funding, and number of lead investors).
  • Elaborate profiles of prominent tissue engineering companies that are currently engaged in offering tissue engineering-based regeneration products. Each profile features a brief overview of the company (including information on the year of establishment, number of employees, location of headquarters, and key executives). Additionally, the chapter includes the company's tissue regeneration product portfolio, details related to its recent developments, and an informed future outlook.
  • An analysis of the various partnerships that have been inked between several stakeholders in the tissue engineering market of tissue engineering-based regeneration products since 2017, covering various types of partnership such as mergers and acquisitions, distribution agreements, product development and commercialization agreements, product utilization agreements, R&D agreements and others, along with analysis on recent investments since 2018 (till the time of analysis) including grant, debt, seed funding, venture series, IPO, private equity, private placement, other equity and others. Further, it includes an analysis of other recent initiatives taken by various stakeholders engaged in the tissue engineering market.
  • An insightful analysis of filed / granted patents focused on tissue engineering-based regeneration products since the last five years (till the month when the research / analysis was conducted). The analysis highlights key details and trends associated with these patents, including patent type (granted patents / patent application / search reports / limited patent), publication year, geographical location (North America / Europe / Asia-Pacific / World Intellectual Property Organization), assigned CPC symbol, emerging focus area, type of applicant (industry / non-industry) and leading industry / non-industry players (in terms of size of intellectual property portfolio). It also includes a patent benchmarking analysis and a detailed valuation analysis.
This image provides information on patents that have been filed / granted related to Tissue Engineering based Regeneration Products The current and future market trends of Tissue Engineering based Regeneration Products Market according to Roots Analysis The market segments of Tissue Engineering based Regeneration Products domain based on the research report of Roots Analysis
  • An analysis that provides information on more than 750 grants that were awarded to various research institutes engaged in studies related to tissue engineering-based regeneration products, during the period 2018 and 2024 (till the time of analysis). The analysis also highlights important parameters associated with grants; The analysis also highlights important parameters associated with grants, such as year of award, support period, amount awarded, funding institute, administration institute center, funding institute center, funding mechanism, spending categorization, grant type (research grants (r series) / research training and fellowships (t & f series) / program project/center grants (p series) / others), responsible study section, focus area, type of recipient organization (schools of medicine / biomedical engineering /college of engineering/ schools of arts and sciences / independent hospitals / domestic for-profits / other domestic non-profits / schools of dentistry/oral hygiene / research institutes / domestic higher education / others) and prominent program officers.

Frequently Asked Questions

Question 1: What are tissue engineering products?

Answer: Tissue engineering products or therapies are tissue grafts used for the replacement, repair, or regrowth of damaged human tissue.

Question 2: What is the global market for tissue engineering?

Answer: The tissue engineering market size is estimated to be worth USD 4,341 million in 2024.

Question 3: What is the projected CAGR of the tissue engineering market?

Answer: The tissue engineering market is expected to grow at a compounded annual growth rate (CAGR) of 10.27% during the forecast period 2024 - 2035.

Question 4: Who are the leading companies in the tissue engineering industry?

Answer: The leading companies in the tissue engineering industry are AlloSource, BioTissue, Integra LifeSciences, MiMedx, Organogenesis, Smith + Nephew, Tissue Regenix and VIVEX Biologics.

Question 5: How many tissue engineering products are currently offered by players engaged in the tissue engineering industry?

Answer: Presently, over 150 products are offered by close to 60 tissue engineering companies.

Question 6: Which region is the hub for companies operating in the tissue engineering market?

Answer: North America and Europe presently emerged as the key hubs, featuring the presence of the highest number of tissue engineering companies.

Question 7: How much funding has been raised by players engaged in the tissue engineering industry?

Answer: The players engaged in the tissue engineering market have raised over USD 2 billion in recent years, highlighting the interest of stakeholders in the regenerative medicine industry.

Question 8: Is tissue engineering a growing field?

Answer: Driven by the ongoing pace of innovation in this field, coupled with the recent shift in preference from traditional transplant procedures to tissue-engineered regeneration products, we believe that the tissue engineering market is likely to witness significant growth in the foreseen future.

Question 9: What are the trends in tissue engineering?

Answer: Technological advancements such as integration of 3D bioprinting and organ-on-chip.

PRICING DETAILS

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print Read more about Single-User License

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple Read more about One Location Site License

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer Read more about Department License

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the Read more about Enterprise License

Discounts available for multiple report purchases
Click here to send an email to Roots Analysis team. sales@rootsanalysis.com